- Tytuł:
- Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)
- Autorzy:
- Źródło:
- In Lung Cancer April 2022 166:107-113
Czasopismo naukowe